Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

GoodRx vs Ro

GoodRx and Ro both sell orforglipron; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GoodRx logo

GoodRx

6.9
★★★★☆3.5/5

Best for: oral orforglipron alongside the injectables

Visit GoodRx →
VS
Ro logo

Ro

6.7
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC

Visit Ro →

If you are choosing between GoodRx and Ro, price alone will not settle it. Both prescribe orforglipron, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 6.7.

GoodRx vs Ro price

GoodRx and Ro start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Orforglipron costs the same at both, $149 a month.

Medications and formats

Both sell orforglipron; only GoodRx lists tirzepatide.

On format they match: each offers brand-name pens.

Where each one treats patients

GoodRx lists 50 states, and Ro does not publish where it ships.

Pricing

GoodRx

Foundayo (lowest dose, self-pay)Brand-name
$149/mo
orforglipron
Zepbound KwikPen (self-pay)Brand-name
$299/mo
tirzepatide

Ro

Foundayo (lowest dose, cash pay)Brand-name
$149/mo
orforglipron

Additional membership fees apply

What each price covers

Ro's price also covers the clinician visit, lab work and coaching, which GoodRx does not claim.

GoodRx does not say what its price includes.

Ro is silent on shipping.

GoodRx

Inclusions not disclosed.

Ro

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

In the price

Coaching

In the price

Where each one scores higher

Overall, GoodRx scores 6.9 and Ro 6.7 out of 10.

GoodRx is stronger on effectiveness (10.0 vs 8.0) and accessibility (10.0 vs 5.0).

Ro is stronger on user experience (8.0 vs 5.0), trust & safety (8.0 vs 6.0) and support (5.5 vs 5.0).

Value is within half a point.

How we score

GoodRx

6.9/10

Overall

Ro

6.7/10

Value25%

5.0A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
8.0

User Experience15%

5.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
8.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.0A
vs
B
5.5

FDA warning letters

Neither GoodRx nor Ro has an FDA warning letter on record with us.

Features & Coverage

FeatureGoodRxRo
Starting Price$149/mo$149/mo
Features6 features✓7 features
States Available50Not disclosed
Compounded——
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About GoodRx

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.

Read our full GoodRx review →

About Ro

Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.

Read our full Ro review →

Pros & Cons

GoodRx

What we like

  • Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
  • Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Serves all 50 states
  • We found no FDA warning letters issued to GoodRx

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Ro

What we like

  • Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits, lab work and coaching
  • Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
  • We found no FDA warning letters issued to Ro

Watch-outs

  • Not included in the monthly price: medication
  • Confirm it serves your state before you start the intake

Our Verdict

Winner: GoodRx

GoodRx wins this one, 6.9 to 6.7, above all for oral orforglipron alongside the injectables. Ro fits better if knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC is your priority.

Choose GoodRx if…

You want oral orforglipron alongside the injectables and an opening price near $149 a month.

Choose Ro if…

You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

GoodRx vs Ro: FAQ

Neither on the entry price: GoodRx and Ro both start at about $149 a month. The difference is in what the price includes.
Yes, both sell orforglipron. GoodRx adds tirzepatide.
GoodRx lists 50 states; Ro does not publish where it ships. Confirm your state before paying.
Only Ro includes the clinician visit, lab work and coaching.
GoodRx has none. Ro has none.
No. Neither GoodRx nor Ro pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.